Cargando…
Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology
α-Synuclein (α-syn), as a primary pathogenic protein in Parkinson’s disease (PD) and other synucleinopathies, exhibits a high potential to form polymorphic fibrils. Chemical ligands have been found to involve in the assembly of α-syn fibrils in patients’ brains. However, how ligands influence the fi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307803/ https://www.ncbi.nlm.nih.gov/pubmed/35869048 http://dx.doi.org/10.1038/s41467-022-31790-7 |
_version_ | 1784752843516805120 |
---|---|
author | Tao, Youqi Sun, Yunpeng Lv, Shiran Xia, Wencheng Zhao, Kun Xu, Qianhui Zhao, Qinyue He, Lin Le, Weidong Wang, Yong Liu, Cong Li, Dan |
author_facet | Tao, Youqi Sun, Yunpeng Lv, Shiran Xia, Wencheng Zhao, Kun Xu, Qianhui Zhao, Qinyue He, Lin Le, Weidong Wang, Yong Liu, Cong Li, Dan |
author_sort | Tao, Youqi |
collection | PubMed |
description | α-Synuclein (α-syn), as a primary pathogenic protein in Parkinson’s disease (PD) and other synucleinopathies, exhibits a high potential to form polymorphic fibrils. Chemical ligands have been found to involve in the assembly of α-syn fibrils in patients’ brains. However, how ligands influence the fibril polymorphism remains vague. Here, we report the near-atomic structures of α-syn fibrils in complex with heparin, a representative glycosaminoglycan (GAG), determined by cryo-electron microscopy (cryo-EM). The structures demonstrate that the presence of heparin completely alters the fibril assembly via rearranging the charge interactions of α-syn both at the intramolecular and the inter-protofilamental levels, which leads to the generation of four fibril polymorphs. Remarkably, in one of the fibril polymorphs, α-syn folds into a distinctive conformation that has not been observed previously. Moreover, the heparin-α-syn complex fibrils exhibit diminished neuropathology in primary neurons. Our work provides the structural mechanism for how heparin determines the assembly of α-syn fibrils, and emphasizes the important role of biological polymers in the conformational selection and neuropathology regulation of amyloid fibrils. |
format | Online Article Text |
id | pubmed-9307803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93078032022-07-24 Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology Tao, Youqi Sun, Yunpeng Lv, Shiran Xia, Wencheng Zhao, Kun Xu, Qianhui Zhao, Qinyue He, Lin Le, Weidong Wang, Yong Liu, Cong Li, Dan Nat Commun Article α-Synuclein (α-syn), as a primary pathogenic protein in Parkinson’s disease (PD) and other synucleinopathies, exhibits a high potential to form polymorphic fibrils. Chemical ligands have been found to involve in the assembly of α-syn fibrils in patients’ brains. However, how ligands influence the fibril polymorphism remains vague. Here, we report the near-atomic structures of α-syn fibrils in complex with heparin, a representative glycosaminoglycan (GAG), determined by cryo-electron microscopy (cryo-EM). The structures demonstrate that the presence of heparin completely alters the fibril assembly via rearranging the charge interactions of α-syn both at the intramolecular and the inter-protofilamental levels, which leads to the generation of four fibril polymorphs. Remarkably, in one of the fibril polymorphs, α-syn folds into a distinctive conformation that has not been observed previously. Moreover, the heparin-α-syn complex fibrils exhibit diminished neuropathology in primary neurons. Our work provides the structural mechanism for how heparin determines the assembly of α-syn fibrils, and emphasizes the important role of biological polymers in the conformational selection and neuropathology regulation of amyloid fibrils. Nature Publishing Group UK 2022-07-22 /pmc/articles/PMC9307803/ /pubmed/35869048 http://dx.doi.org/10.1038/s41467-022-31790-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tao, Youqi Sun, Yunpeng Lv, Shiran Xia, Wencheng Zhao, Kun Xu, Qianhui Zhao, Qinyue He, Lin Le, Weidong Wang, Yong Liu, Cong Li, Dan Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
title | Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
title_full | Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
title_fullStr | Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
title_full_unstemmed | Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
title_short | Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
title_sort | heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307803/ https://www.ncbi.nlm.nih.gov/pubmed/35869048 http://dx.doi.org/10.1038/s41467-022-31790-7 |
work_keys_str_mv | AT taoyouqi heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT sunyunpeng heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT lvshiran heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT xiawencheng heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT zhaokun heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT xuqianhui heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT zhaoqinyue heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT helin heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT leweidong heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT wangyong heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT liucong heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology AT lidan heparininducesasynucleintoformnewfibrilpolymorphswithattenuatedneuropathology |